Cannabis Investing Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Cannabis Investing Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Cannabis Investing Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
Cannabis Investing Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
Lexaria Receives Independent Review Board Approval For DehydraTECH-CBD Human Clinical Study HYPER-H21-4
Lexaria's DehydraTECHTM-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2
Lexaria's DehydraTECH-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2
Forte Minerals Closes a Second C$5.7 Million Strategic Investment and Additional Participation from Existing Strategic Investor
LaFleur Minerals Provides Update on Confirmation Drilling for PEA at Swanson Gold Deposit and Beacon Gold Mill, Val-d'Or, Québec
Cartier Cuts 111.5 g/t Au over 2.0 m at Contact ; Confirms Multiple High-Grade Gold Zones; Extends Drilling at Surface
